大动脉狭窄:诊断,分子机制和治疗策略 - - 一个全面的审查
Cosmin Marian Banceu1,2, Daiana Cristutiu2, Simona Gurzu3,4
1Department ME 2, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540139 Targu Mures, Romania.
Journal of clinical medicine
|July 29, 2025
概括
超导管大动脉置换 (TAVR) 越来越多地用于大动脉狭窄 (AS),由于潜在的门耐用性问题,对年轻患者构成挑战. 心脏门团队在TAVR和外科主动脉置换 (SAVR) 之间选择时面临不确定性.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 生物医学工程 生物医学工程
背景情况:
- 大动脉狭窄 (AS) 是一种渐进的膜心脏病,导致显著的发病率和死亡率.
- 手术性大动脉置换 (SAVR) 是传统的治疗方法,但越来越多地采用过导管大动脉置换 (TAVR).
- TAVR已被批准用于各种手术风险级别的患者,改变了AS管理.
研究的目的:
- 为应对在65岁以下患者中TAVR使用量的增加所带来的挑战.
- 探索严重大动脉狭窄症患者在TAVR和SAVR之间选择治疗的不确定性.
- 为心脏门团队 (HVTs) 在管理AS的年轻人提供信息.
主要方法:
- 本摘要没有指定方法.
- 该研究可能涉及对当前治疗指南和患者结果的审查或分析.
- 为了提供全面的总结,需要进一步详细说明方法.
主要成果:
- 在年轻人 (65岁以下) 中,TAVR的日益应用是一个挑战.
- 年轻患者的预期寿命延长引发了人们对TAVR门与其寿命相比的耐用性的担忧.
- 在选择TAVR和SAVR之间仍然存在重大不确定性,特别是在老年患者 (65岁以上) 中.
结论:
- 越来越多的TAVR使用需要仔细考虑门的耐用性,特别是在年轻的患者.
- 需要进一步的研究,以指导心脏门团队优化大动脉狭窄的治疗策略.
- 长期结果和TAVR与SAVR的比较有效性需要继续调查.
相关概念视频
Aortic Regurgitation III: Medical Management
44
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
44
Mitral Stenosis III: Medical Management
23
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
23
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Aortic Regurgitation I: Introduction
38
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
38
Aneurysm III: Interprofessional Care
26
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
26
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37


